Microbix Biosystems (TSE:MBX) Stock Crosses Above 50 Day Moving Average – Here’s Why

Shares of Microbix Biosystems Inc. (TSE:MBX) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$0.45 and traded as high as C$0.48. Microbix Biosystems shares last traded at C$0.47, with a volume of 43,273 shares changing hands.

Microbix Biosystems Stock Performance

The firm has a market cap of C$61.90 million, a price-to-earnings ratio of 17.91 and a beta of 0.34. The firm’s 50 day moving average is C$0.45 and its 200-day moving average is C$0.38. The company has a debt-to-equity ratio of 22.61, a quick ratio of 5.57 and a current ratio of 7.15.

Insiders Place Their Bets

In related news, Director Cameron Lionel Groome sold 200,000 shares of the company’s stock in a transaction on Wednesday, January 22nd. The shares were sold at an average price of C$0.43, for a total transaction of C$86,500.00. Also, Director Bo Hollas sold 150,000 shares of Microbix Biosystems stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of C$0.49, for a total transaction of C$73,500.00. Insiders sold 400,000 shares of company stock valued at $181,000 over the last quarter. Insiders own 14.00% of the company’s stock.

Microbix Biosystems Company Profile

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.